Definitive Contract 75D30118C02804
Award Date 8/15/18
Potential Completion Date 8/14/23
Potential Value $1.7M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,085,922,457.04 firm fixed price contract to Glaxosmithkline, LLC for the provision of vaccines for children. The contract, which did not have a set-aside designation, has a performance period ending on March 31, 2018. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines, antivirals, and other pharmaceutical products to federal agencies including the...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, to procure $40,551,654.40 in products. The contract has no set-aside designation. Glaxosmithkline provides various pharmaceutical goods and services to multiple federal agencies, including vaccines, antiviral medications, and drug development support. This award was likely made under one of Glaxosmithkline's...
- This is a federal contract award to GlaxoSmithKline, LLC, a pharmaceutical company, by the Centers for Disease Control and Prevention (CDC) for the provision of influenza vaccines. The contract, valued at $9,888,000.00, is a definitive contract with a firm fixed price. The award was made on December 18, 2015, and the ultimate completion date is February 28, 2017. The contract has no set-aside designation, and the place of performance is in Research Triangle Park, North Carolina....
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC on December 23, 2016 for the 2017 adult flu season. The firm fixed price contract has a ceiling value of $12,408,000.00 and a performance period ending February 28, 2018. The contract does not have a set-aside designation. GlaxoSmithKline, a pharmaceutical company, has provided a range of products to U.S. government agencies through federal contracts, including influenza...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a delivery order to GlaxoSmithKline, LLC on August 15, 2023, for the borrow and return of stockpile vaccine doses. This administrative modification represents a firm fixed-price delivery order with a ceiling value of $2.76 million and an ultimate completion date of August 14, 2028. The contract, which carries no set-aside designation, is performed in Durham, North Carolina, where GlaxoSmithKline maintains its U.S....
- This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline. The $12,136,000.00 firm fixed price contract is for the delivery of adult influenza (flu) vaccines. The contract has no set-aside designation and the place of performance is in Atlanta, Georgia. Glaxosmithkline is a pharmaceutical company that provides various vaccines, antiviral medications, and other...
- This is a $50,556,695.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, titled "2016 VFA - GSK", is for a firm fixed price and has an ultimate completion date of June 30, 2017. It is not a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and...
- The Centers for Disease Control and Prevention (CDC) awarded a delivery order to Merck Sharp & Dohme LLC for vaccine storage and rotation services under a five-year period of performance extending through September 15, 2026. This administrative modification enables the borrowing and return of stockpile vaccine doses, supporting CDC's critical vaccine management operations. The contract is structured as a firm fixed-price delivery order with a ceiling value of $6.43 million and carries no...